Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an anti-CD151 antibody in the treatment of cancer

Use of an anti-CD151 antibody in the treatment of cancer

US Patent 8178096 · Granted May 15, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfomaleimide-based linkers and corresponding conjugates2024
Immunocytokines for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody and its use as addressing vehicle for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Composition for the treatment of IGF-1R expressing cancer2020
Composition for the treatment of IGF-1R expressing cancer2020
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2020
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2020
Antibody-drug-conjugate and its use for the treatment of cancer2019